Association of factor VII protein concentration with lifestyle factors

REFERENCES

• Meade TW, Brozovic M, Chakrabarti R, Haines AP, Imeson JD, Mellows S, et al. Haemostatic function and ischaemic heart disease: Principal results of The Northwick Park Heart Study. Lancet 1986; ii: 533–7.
   Google Scholar
• Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076–9.
   Google Scholar
• Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the predic-tion of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54–9.
   Google Scholar
• Balleisen L, Bailey J, Epping PH, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and meno-pause. Thromb Haemost 1985; 54: 475–9.
   Google Scholar
• Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population—II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985; 54: 721–3.
   Google Scholar
• Folsom AR, Qamhieh HT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moder-ately overweight adults. Arterioscler Thromb 1993; 13: 162–9.
   Google Scholar
• Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemo-static variables associated with diabetes and its complications. Br Med J 1979; 2: 964–6.
   PubMed Web of Science ®Google Scholar
• Brozovic M, Stirling Y, Harricks C, North WRS, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381–91.
   PubMedGoogle Scholar
• Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardio-vascular risk factors. Atherosclerosis 1991; 91: 191–205.
   PubMed Web of Science ®Google Scholar
• Dalaker K, Prydz H. The coagulation factor VII in pregnancy. Br J Haematol 1984; 56: 233–41.
   PubMedGoogle Scholar
• Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagula-tion and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767–71.
   PubMed Web of Science ®Google Scholar
• Marckmann P, Sandstrom B, Jespersen J. Favor-able long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505–11.
   Google Scholar
• Marckmann P, Sandstrom B, Jespersen J. Low-fat high-fiber diet favorably affects several independent risk markers of ischemic heart disease. Observa-tions on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935–9.
   Google Scholar
• Bladbjerg EM, Marckmann P, Sandstrom B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755–8.
   PubMed Web of Science ®Google Scholar
• Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72–6.
   PubMed Web of Science ®Google Scholar
• Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and purified systems. J Clin Invest 1979; 64: 1056–65.
   Google Scholar
• Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and oral contraceptives. Thromb Res 1993; 70: 275–80.
   Google Scholar
• Bruckert E, Carvalho de Sousa JC, Giral P, Soria C, Chapman MJ, Caen J, de Gennes JL. Inter-relationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolaemia. Atherosclerosis 1989; 75: 129–34.
   PubMed Web of Science ®Google Scholar
• Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi MC, et al. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemia: A clinical and laboratory study. Haemostasis 1989; 19: 83–90.
   PubMedGoogle Scholar
• Carvalho de Sousa J, Bruckert E, Soria C, Caen JP. Phospholipase C sensitive factor VII activity and factor VII antigen in hypertriglyceridaemia. Nouv Rev Fr Hematol 1989; 31: 13–5.
   PubMedGoogle Scholar
• Hoffman C, Shah A, Sodums M, Hultin MB. Fac-tor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475–81.
   PubMedGoogle Scholar
• Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol 1989; 14: 941–6.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, Saito H. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731–6.
   Google Scholar
• Bladbjerg EM, Tholstrup T, Marckmann P, SandstrOm B, Jespersen J. Dietary changes in fast-ing levels of factor VII coagulant activity (FVII:C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995; 73: 239–42.
   Google Scholar
• Marckmann P, Sandstrom B, Jespersen J. Effects of total fat content and fatty acid composition on fac-tor VII coagulant activity and blood lipids. Athero-sclerosis 1990; 80: 227–33.
   Google Scholar
• Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60–9.
   PubMed Web of Science ®Google Scholar
• Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, etal. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1–11.
   Google Scholar
• Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterios-cler Thromb 1992; 12: 267–70.
   Google Scholar
• Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting fac-tors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737–40.
   PubMedGoogle Scholar
• Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and menopausal status. Thromb Res 1990; 57: 227–34.
   PubMedGoogle Scholar
• Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21–7.
   Google Scholar
• Douglas AS. Anticoagulant therapy. Oxford: Blackwell Scientific, 1962: 16–8.
   Google Scholar
• Bladbjerg EM, Overgaard K, Gram J, Jespersen J. The protein concentration of blood coagulation fac-tor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest 1995; 55: 267–71.
   PubMed Web of Science ®Google Scholar
• Hollnagel H. 40-driges helbred. Thesis. Copenha-gen: University of Copenhagen, 1985
   Google Scholar
• Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. Geneva: WHO, 1982
   Google Scholar
• Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody precipitate. J Biochem 1963; 88: 137–46.
   Google Scholar
• Astrup T, Brakman P, Nissen U. The estimation of fibrinogen. Scan J Clin Lab Invest 1965; 17: 57–65.
   PubMed Web of Science ®Google Scholar
• Moller L, Kristensen TS. Plasma fibrinogen and ischaemic heart disease risk factors. Arterioscler Thromb 1991; 11: 344–50.
   PubMed Web of Science ®Google Scholar
• Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 1992; 67: 351–4.
   Google Scholar
• Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lan-cet 1987; ii: 986–8.
   Google Scholar
• Prisco D, Fedi S, Brunelli T, Cellai AP, Hagi MI, Gianni R, et al. Fibrinogen and factor VIIag in healthy adolescents: The Floren-teen (Florence Teenager) Study. Thromb Haemost 1996; 75: 778–81.
   PubMedGoogle Scholar
• Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and anti-gen levels in healthy men are determined by inter-action between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193–8.
   Google Scholar
• Marongiu F, Biondi G, Sorano GG, Mameli G, Conti M, Mamusa AM, etal. Bleeding time is pro-longed during oral anticoagulant therapy. Thromb Res 1990; 59: 905–12.
   Google Scholar
• Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vita-min K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541–9.
   PubMedGoogle Scholar
• Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factor VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940–4.
   Google Scholar
• Moller LF, Jespersen J. Fasting serum insulin levels and the coronary heart disease in a Danish cohort: 17-years follow-up. J Cardiovasc Risk 1995; 2: 235–40.
   PubMedGoogle Scholar